Mexico

Study populations 

Mexico, in 2016, had an estimated population of 123.1m with 27% under the age of 15 years and 11% over the age of 60 years. By 2050, Mexico will have aged considerably – with older people representing some 30% of the total population or 45m.

Alongside the ageing population, diabetes prevalence is increasing – with the most recent statistics reporting 11.5m people living with the condition rising in 2040 to 20.6m. There are an estimated 3.9m undiagnosed cases.

Report & Infographic 

Cover page for Mexico Study Report. For accessible PDF version of full report click the image.
Info-graphic containing overview of findings. For an accessible PDF please click the image.

Time of presentation for screening with an opthamologist

)% In time for screening, 75% When visual problems have already occurred, 25% Too late for effective treatment
(Opthamologists n=20)
In time for screening When visual problems have already occurred Too late for effective treatment

Percentage of adults with diabetes who have completed an Eye Exam

49.8% Have had an eye exam, 50.2% Never had an eye exam
(Adults with diabetes n=261)
Have had an eye exam
Never had an eye exam
 

Availability of DR patient education materials in health care providers’ offices

20.5% Sufficient information available, 36.4% Information not sufficient, 43.2% No written information available, 0% Don’t know
(All providers n=44)
Sufficient information available Information not sufficient No written information available Don’t know

Frequency of discussions about eye complications with health care providers

18.9% Every visit, 8.5% Multiple times per year, 24.8% Once a year, 27.8% When symptoms arise, 17.8% Never
(Adults with diabetes n=270)
Every visit Multiple times per year Once a year When symptoms arise Never
banner-join-community

The DR Barometer Community is a growing multidisciplinary network of thought leaders and organizations who are working together to address gaps in diabetes patient care. Join today to help improve vision health outcomes among people living with diabetes.